Abstract:BackgroundBone morphogenetic protein-2 (BMP2) has been successfully utilized in dentistry to promote new bone formation because of its osteoinductive ability to recruit mesenchymal progenitor cells and induce their differentiation to bone-forming osteoblasts. Recently, novel biphasic calcium phosphate scaffolds have been developed with similar osteoinductive properties capable of forming ectopic bone formation.PurposeThe aim of the present study was to assess whether the combination of BMP2 with this novel Biphasic Calcium Phosphate (BCP) scaffold may additionally promote new bone regeneration.Materials and MethodsCylindrical bone defects measuring 2.5mm were created bilaterally in the femurs of 18 Wistar rats. After 4 weeks, the following six groups were assessed for new bone formation by micro-computed tomography (CT) as well as histological assessment: 1) collagen scaffolds+20g of BMP2; 2) collagen scaffolds+50g of BMP2; 3) collagen scaffolds+100g of BMP2; 4) BCP scaffolds+20g of BMP2; 5) BCP scaffolds+50g of BMP2; and 6) BCP scaffolds+100g of BMP2. Furthermore, tartrate-resistant acid phosphatase (TRAP) staining was utilized to assess osteoclast activity and osteoclast number. The release kinetics of BMP2 from both BCP and collagen scaffolds was investigated over a 14-day period.ResultsThe results from present study demonstrate that BMP2 is able to promote new bone formation in a concentration dependant manner when loaded with either a collagen scaffolds or BCP scaffolds. Micro-CT analysis demonstrated significantly higher levels of new bone formation in groups containing BCP+BMP2 when compared with collagen scaffolds+BMP2. BMP2 had little effect on osteoclast activity; however, less TRAP staining and osteoclast number was observed in the defects receiving collagen scaffolds when compared with BCP scaffolds. The release of BMP2 over time was rapidly released after 1 day on BCP scaffolds whereas a gradually release over time was observed for collagen scaffolds up to 14 days.ConclusionThe osteoinductive properties of BMP2 may further be enhanced by its combination with a novel synthetically fabricated osteoinductive BCP scaffold. Future clinical testing is required to further assess these preliminary findings.

The Osteogenic Effect of Bone Morphogenetic Protein-2 on the Collagen Scaffold Conjugated with Antibodies

Studies on Recombinant Human Bone Morphogenetic Protein 2 Loaded Nano-Hydroxyapatite/Silk Fibroin Scaffolds

Cell Biocompatibility of Hydroxyapatite/Silk Fibroin Composite Scaffolds Carrying Bone Morphogenetic Protein

Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2.

The Bone-Derived Collagen Containing Mineralized Matrix For The Loading Of Collagen-Binding Bone Morphogenetic Protein-2

The effect of crosslinking heparin to demineralized bone matrix on mechanical strength and specific binding to human bone morphogenetic protein-2.

Effect of Mineralized Recombinant Collagen Bone Modified with BMP-2-derived Peptide on Biological Behavior of Bone Marrow Stromal Cells

Localization and Promotion of Recombinant Human Bone Morphogenetic Protein-2 Bioactivity on Extracellular Matrix Mimetic Chondroitin Sulfate-Functionalized Calcium Phosphate Cement Scaffolds.

Collagen-binding bone morphogenetic protein-2 designed for use in bone tissue engineering

Tuning the Bioactivity of Bone Morphogenetic Protein-2 with Surface Immobilization Strategies

Collagen sponge functionalized with chimeric anti-BMP-2 monoclonal antibody mediates repair of nonunion tibia defects in a nonhuman primate model: An exploratory study

Newly Designed Human-Like Collagen to Maximize Sensitive Release of BMP-2 for Remarkable Repairing of Bone Defects

Addition of a Synthetically Fabricated Osteoinductive Biphasic Calcium Phosphate Bone Graft to BMP2 Improves New Bone Formation

The Osteogenesis of Bacterial Cellulose Scaffold Loaded with Bone Morphogenetic Protein-2

Calcium sulfate hemihydrate/mineralized collagen for bone tissue engineering: In vitro release and in vivo bone regeneration studies

Effect of rhBMP-2 on the Osteogenesis of Osteoblast Compounded Chitosan

Enhancement of Bone Formation by Bone Morphogenetic Protein-2 Released from Poly (L-Lactic-co-glycolic Acid) Microsphere

Heparin-mediated delivery of bone morphogenetic protein-2 improves spatial localization of bone regeneration

Enhancement of bone formation by recombinant human bone morphogenetic protein-2/chitosan bone biomaterials

Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo.

Controlled Release of BMP-2 from a Collagen-Mimetic Peptide-Modified Silk Fibroin-Nanohydroxyapatite Scaffold for Bone Regeneration.